Thrombolytics for acute ischemic stroke: Difference between revisions

No edit summary
Line 59: Line 59:
#Glu check  
#Glu check  
#ECG  
#ECG  
#Icon
#Urine pregnancy


== tPA Administration  ==
== tPA Administration  ==
#Alteplase 0.9mg/kg IV (max 90mg total)  
#Alteplase 0.9mg/kg IV (max 90mg total)  
##Load with .09mg/kg (10% of dose) as IV bolus over 1min, followed by 0.81mg/kg (90% of dose) as cont. infusion over 60min  
##10% of dose is administered as bolus; rest is given over 60min
#Neuo check Q15min x 2hrs, Q30min x6hrs, Q1hr x 16hrs
#Neuo check Q15min x 2hr
#Keep BP <180/105  
#No anticoatulation/antiplatelets x 24hr
##Labetalol 10mg IV followed by continous IV infusion 2-8mg/min OR  
#Blood pressure
##Nicardipine IV 5mg/h, titrate up to desired effect by 2.5mg/hr q 5-15min, maximum 15mg/h
##Keep SBP <180, DBP <105
##If BP not controlled or dia &gt; 140 consider nitroprusside
##If SBP is 180-230 or DBP is 105-120:
#No anticoatulation/antiplatelets x 24hrs
###Labetalol 10mg IV over 1–2 min; repeat dose q10–20min up to 300mg max OR
#Stop tPA and consider head CT if pt develops:
###Labetalol 10mg IV followed by infusion at 2–8 mg/min
##Neuro changes
##If SBP is >230 or DBP 121-140:
##Acute hypertension
###Labetalol as above OR
##Nausea/vomiting
###Nicardipine 5mg/hr; titrate up by 2.5 mg/hr at 5-15min intervals; max dose 15mg/hr
##If BP not controlled by above measures:
###Nitroprusside 0.5–10mcg/kg/min
####Continuous arterial monitoring advised
####Use w/ caution in pts with hepatic or renal insufficiency


== Complications ==
==tPA Complications==
[[Post-tPA Hemorrhage]]  
*[[Post-tPA Hemorrhage]]  
*Angioedema


== See Also  ==
== See Also  ==

Revision as of 08:29, 28 September 2011

Background

  1. NINDS Trial (pts treated within 3hrs)
    1. Benefits:
      1. 12% absolute risk reduction benefit (NNT = 8-9) at 3 months
        1. Lower percentage of pts who left hospital severely disabled
      2. Comparable 3-month mortality rate (even with increased rate of ICH)
    2. Risks:
      1. Intracranial hemorrhage occurs in 6.4% of treated pts
  2. ECASS Trial (pts treated within 4.5hrs)
    1. Confirmed NINDS findings even when therapeutic window extended to 4.5hr
    2. As a result AHA/ASA now recommends tPA for pts presenting up to 4.5hr after sx onset

tPA <3hr

Inclusion Criteria

  1. Diagnosis of ischemic stroke causing measurable neuro deficit
  2. Clear onset (last witnessed well) <3hr (see below for extension to <4.5hr)
  3. Age >18yr

Exclusion Criteria

(Only need to wait for plt, INR, PTT if there is clinical suspicion of abnormal value, pt has received heparin or warfarin, or use of anticoagulants is unknown)

  1. Historical
    1. Stroke or head trauma in previous 3 months
    2. Any history of intracranial hemorrhage
    3. Major surgery in the previous 14 days
    4. GI or urinary tract bleeding in previous 21 days
    5. MI in previous 3 months
    6. Arterial puncture at noncompressible site in previous 7 days
  2. Clinical
    1. Spontaneously clearing stroke symptoms
    2. Only minor and isolated neurologic signs
    3. Seizure at onset of stroke if residual impairments are due to postictal phenomenon; #Symptoms of stroke suggestive of SAH
  3. Persistent SBP >185 or DBP >110 despite treatment
  4. Active bleeding or acute trauma (fracture) on exam
  5. Labs
    1. Platelets <100K
    2. Serum glucose <50
    3. INR >1.7 if on warfarin
    4. Elevated PTT if on heparin
    5. Use of dabigatran within 48hrs is relative contraindication
  6. Head CT
    1. Evidence of hemorrhage
    2. Evidence of multilobar infarction w/ hypodensity involving >33% of cerebral hemisphere

tPA between 3-4.5hrs

Inclusion Criteria

  1. Same as for <3hr

Exclusion Criteria

  1. All of the above plus:
    1. Age >80yr
    2. Combination of both previous stroke and DM
    3. NIHSS score >25
    4. Oral anticoagulant use regardless of INR

Studies Needed

  1. Head CT
  2. CBC
  3. Coags
  4. Glu check
  5. ECG
  6. Urine pregnancy

tPA Administration

  1. Alteplase 0.9mg/kg IV (max 90mg total)
    1. 10% of dose is administered as bolus; rest is given over 60min
  2. Neuo check Q15min x 2hr
  3. No anticoatulation/antiplatelets x 24hr
  4. Blood pressure
    1. Keep SBP <180, DBP <105
    2. If SBP is 180-230 or DBP is 105-120:
      1. Labetalol 10mg IV over 1–2 min; repeat dose q10–20min up to 300mg max OR
      2. Labetalol 10mg IV followed by infusion at 2–8 mg/min
    3. If SBP is >230 or DBP 121-140:
      1. Labetalol as above OR
      2. Nicardipine 5mg/hr; titrate up by 2.5 mg/hr at 5-15min intervals; max dose 15mg/hr
    4. If BP not controlled by above measures:
      1. Nitroprusside 0.5–10mcg/kg/min
        1. Continuous arterial monitoring advised
        2. Use w/ caution in pts with hepatic or renal insufficiency

tPA Complications

See Also

Source

  • Tintinalli
  • Hacke W, Kaste M, Bluhmi E, et al: Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med 359(13): 1317, 2008
  • ACEP/AAN Guidelines
  • AHA/ASA Guidelines